N@N

CHIX, FOR, IRV, ULE, OSIR Are Seasonally Ripe To Go Down In the Next Five Weeks

January 26, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of Global X China Financials ETF (NYSE:CHIX), Forestar Group Inc. (NYSE:FOR), SPDR S&P International Materials Sector ETF (NYSE:IRV), ProShares Ultra Euro (NYSE:ULE), Osiris Therapeutics Inc. (NASDAQ:OSIR) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  CHIX    Global X China Financials ETF    -1.04%           100.00% (7 of 7)     Monday, February 6th 2017
  FOR     Forestar Group Inc.              -3.26%           88.89% (8 of 9)      Tuesday, January 31st 2017
  IRV     SPDR S&P International Materials Sector ETF  -0.92%           87.50% (7 of 8)      Friday, January 27th 2017
  ULE     ProShares Ultra Euro             -1.68%           87.50% (7 of 8)      Monday, January 30th 2017
  OSIR    Osiris Therapeutics Inc.         -8.48%           90.00% (9 of 10)     Thursday, February 9th 2017

Global X China Financials ETF (NYSE:CHIX) - Global X China Financials ETF.

Forestar Group Inc. (NYSE:FOR) - Forestar Group Inc. operates as a real estate, and oil and gas company in the United States. It operates through three segments: Real Estate, Oil and Gas, and Other Natural Resources. The Real Estate segment engages in the acquisition, entitlement, development, and sale of real estate, primarily residential and mixed-use communities. It also sells commercial tracts; residential lots primarily to homebuilders; and undeveloped land through its retail sales programs, as well as operates income producing properties, such as a hotel and multifamily properties. This segment owns, directly or through ventures, approximately 7,000 acres of real estate located in 11 states and 15 markets in the United States; and has 3 real estate projects representing approximately 4,400 acres in the entitlement process. The Oil and Gas segment focuses on the exploration, development, and production of oil and gas on its owned and leasehold mineral interests. It leases its mineral interests to third parties for the exploration and production of oil and gas. This segment has approximately 590,000 net acres of oil and gas mineral interests located in Texas, Louisiana, Georgia, and Alabama. The Other Natural Resources segment sells wood fiber from portions of its land primarily in Georgia; and leases land for recreational uses. This segment, directly or through ventures, owns approximately 89,000 acres of non-core timberland and undeveloped land. It also holds water interests in about 1.5 million acres. The company is headquartered in Austin, Texas..

SPDR S&P International Materials Sector ETF (NYSE:IRV) - Spdr S&P International Materials Sector.

ProShares Ultra Euro (NYSE:ULE) - Proshares Ultra Euro.

Osiris Therapeutics Inc. (NASDAQ:OSIR) - Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chronic wounds, venous leg ulcers, and burns; BIO4, a bone allograft for use in all surgical applications, including spine, trauma, extremity, cranial, and foot and ankle surgery; and Cartiform, a viable chondral allograft that promotes articular cartilage repair to treat focal chondral defects. It markets and distributes its products directly to hospitals, clinics, and physician offices as well as through agents and distributors. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources

---